Measurement of anti-human cytomegalovirus T cell reactivity in transplant recipients and its potential clinical use: A mini-review

Intervirology

Volumn 42, Issue 5-6, 1999, Pages 322-324

  Kern, Florian ^a   Faulhaber, Nicole ^a   Khatamzas, Elham ^a   Frömmel, Claudia ^a   Ewert, Ralf ^b   Prösch, Susanna ^a   Volk, Hans Dieter ^a   Reinke, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Cellular immune defense; Cytomegalovirus disease; Cytomegalovirus infection; Immunosuppression; Intracellular cytokines; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANTIGEN SPECIFICITY; CELL LYSATE; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; FLOW CYTOMETRY; GRAFT INFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOREACTIVITY; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0343114300     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053967     Document Type: Conference Paper

References (18)

1. Waldrop SL, Pitcher CJ, Peterson DM, Maino VC, Picker LJ: Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 1997;99:1739-1750.
2. Kern F, Surel IP, Brock C, Freistedt B, Radtke H, Scheffold A, Blasczyk R, Reinke P, Schneider-Mergener J, Radbruch A, Walden P, Volk HD: T-cell epitope mapping by flow cytometry. Nat Med 1998;4:975-978.
3. Tan LC, Gudgeon N, Annels NE, Hansasuta P, O'Callaghan CA, Rowland-Jones S, McMichael AJ, Rickinson AB, Callan MF: A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol 1999;162:1827-1835.
4. Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM: Phenotypic analysis of antigen-specific T lymphocytes [published erratum appears in Science 1998;280:1821]. Science 1996;274:94-96.
5. Quinnan GV Jr, Burns WH, Kirmani N, Rook AH, Manischewitz J, Jackson L, Santos GW, Saral R: HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections. Rev Infect Dis 1984;6:156-163.
6. Riddell SR, Walter BA, Gilbert MJ, Greenberg PD: Selective reconstitution of CD8+ cytotoxic T lymphocytes responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones. Bone Marrow Transplant 1994;14(suppl 4):S78-S84.
7. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR: Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995;333:1038-1044.
8. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD: Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238-241.
9. Riddell SR, Greenberg PD: Cellular adoptive immunotherapy after bone marrow transplantation. Cancer Treat Res 1995;76:337-369.
10. Barry SM, Lipman MC, Johnson MA, Prentice HG: Respiratory infections in immunocompromised patients. Curr Opin Pulm Med 1999; 5:168-173.
11. Gatell JM, Marrades R, cl-Ebiary M. Torres A: Severe pulmonary infections in AIDS patients. Semin Respir Infect 1996;11:119-128.
12. Boeckh M, Boivin G: Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clin Microbiol Rev 1998;11:533-554.
13. Reusser P, Cathomas G, Attenhofer R, Tamm M, Thiel G: Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load. J Infect Dis 1999; 180:247-253.
14. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG: The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996;70:7569-7579.
15. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV: Viral clearance without destruction of infected cells during acute HBV infection. Science 1999;284:825-829.
16. Riddell SR, Greenberg PD: Principles for adoptive T cell therapy of human viral diseases. Annu Rev Immunol 1995;13:545-586.
17. Kern F, Khatamzas E, Surel IP, Frömmel C, Reinke P, Waldrop S, Picker LJ, Volk HD: Distribution of human CMV-specific memory T cells among the CD8(pos.) subset defined by CD57, CD27, and CD45 isoforms. Eur J Immunol 1999;29:2908-2915.
18. van den Berg AP, Twilhaar WN, van Son WJ, van der Bij W, Klompmaker IJ, Slooff MJ, The TH, de Leij LH: Quantification of immunosuppression by flow cytometric measurement of intracellular cytokine synthesis. Transpl Int 1998;11(suppl 1):S318-S321.